课题基金 / 基金详情

Immuno-epidemiological insights into the development of immunity to malaria and drug resistance

Immuno-epidemiological insights into the development of immunity to malaria and drug resistance
关于疟疾免疫力和耐药性发展的免疫流行病学见解
批准号:
FT130101122
负责人:
Dr Freya Fowkes
金额:
$55.37万
依托单位国家:
澳大利亚
项目类别:
ARC Future Fellowships
财政年份:
2013
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2013-12-31 至 2019-09-24

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
该项目旨在更好地了解高危人群对疟疾的免疫力的维持和获得。 它还将试图阐明免疫力如何干扰抗疟药物的治疗效果,特别是在评估新出现的耐药性方面。压倒一切的假设是,疟疾传播的差异将导致人群内部和人群之间获得免疫力和疟疾干预措施的效果不同。了解疟疾免疫力对于开发新的干预措施,了解当前疟疾治疗和控制计划的有效性以减少疟疾疾病的全球负担至关重要。
英文摘要
This project aims to better understand the maintenance and acquisition of immunity to malaria in high risk groups. It will also attempt to elucidate how immunity can interfere with the therapeutic efficacy of antimalarials, especially in the assessment of emerging drug resistance. The over-riding hypothesis is that differences in malaria transmission will lead to differential acquisition of immunity and efficacy of malaria interventions within and between populations. Understanding immunity to malaria is pivotal to develop new interventions, to understand the effectiveness of current malaria treatment and control programs to reduce the global burden of malarial disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
眼表菌群影响糖尿病患者干眼发生的人群流行病学研究
  • 批准号:
    82371110
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    邹海东
  • 依托单位: